Infinity Pharma And Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 In Combination With Opdivo (Nivolumab) - BioLegacy Research

Infinity Pharma And Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 In Combination With Opdivo (Nivolumab)

Post author:Sam
Post published:September 24, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace